Temozolomide (TMZ)-resistant recurrent GBM cells (22TMZ, 79TMZ) (Fig. 7H,7I
Temozolomide (TMZ)-resistant recurrent GBM cells (22TMZ, 79TMZ) (Fig. 7H,7I). Rembrandt database inspection revealed that overall survival was better in glioma patients with reduced CypB expression in their tumors (Fig. 7J),…